Markus H Heim

24PUBLICATIONS
117CO-AUTHORS
Haematological tumoursGenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 06, 2026
Multi-omics profiling reveals divergent biology and liver microenvironment in HCC of metastatic and de novo origin.

Gina F Boot, Fabian Haak, Mairene Coto-Llerena

|Nov 07, 2025
Whole-Genome Sequencing of Hepatitis B Virus Genotypes E and A in Zambia Reveals Limited Viral Diversity in HIV Coinfection.

Michael J Vinikoor, Andreas Walker, Bright Nsokolo

|Aug 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

Celia Sequera, Margherita Grattarola, Floriane Cannet

|Feb 19, 2025
Human-correlated genetic models identify precision therapy for liver cancer.

Miryam Müller, Stephanie May, Holly Hall

|May 02, 2024
Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC.

Lauriane Blukacz, Sandro Nuciforo, Geoffrey Fucile

|May 07, 2023
Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS.

Angel N Borisov, Alexander Kutz, Emanuel R Christ

Pageof 4

Frequent Collaborators

8 joint publications

Sandro Nuciforo

7 joint publications

Caner Ercan

6 joint publications

Charlotte K Y Ng

5 joint publications

Salvatore Piscuoglio